Work

Single, High Doses of USL255, an Extended-Release Topiramate Formulation, Are Well Tolerated and Demonstrate a Dose-Proportional Pharmacokinetic Profile in Healthy Subjects (P04.212)

Year: 2013

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.80.7_supplement.p04.212

Authors: Tricia Braun, Annie Clark, James Cloyd, Mark Halvorsen

Institutions: Upsher-Smith Laboratories (United States), University of Minnesota

Language: English

Topic: Epilepsy research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W32232193

FWCI:

Cites:

Cited by:

Related to: 10